Showing 1231-1240 of 1395 results for "".
- Myra Vision Secures FDA Approval to Initiate US-Based IDE Study in Glaucomahttps://modernod.com/news/myra-vision-secures-fda-approval-to-initiate-us-based-ide-study-in-glaucoma/2482933/Myra Vision announced today that the FDA has issued a conditional approval letter for its investigational device exemption (IDE) application, allowing the company to initiate the ADAPT study. The prospective, nonr
- Beyeonics Vision Secures US Patent for Ophthalmic Surgical Visualization Technologyhttps://modernod.com/news/beyeonics-vision-secures-us-patent-for-ophthalmic-surgical-visualization-technology/2482931/Beyeonics Vision announced the issuance of a US patent to protect its core technology for how surgeons visualize the eye during cataract and other ocular procedures. According to Beyeonics, the patent, titled “Systems and Methods for Imaging a
- The Vision Council Comments on Impact of Proposed Tariffs on Optical Industryhttps://modernod.com/news/the-vision-council-comments-on-impact-of-proposed-tariffs-on-optical-industry/2482880/The Vision Council has released a letter summarizing the recent tariffs proposed by the Trump administration and the impact it could have on the optical industry. The White House issued formal notice to several US trading partners outlining tariff
- EMA Review Finds Rare Risk of Vision Loss Associated With Semaglutide Medicineshttps://modernod.com/news/ema-review-finds-rare-risk-of-vision-loss-associated-with-semaglutide-medicines/2482842/The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines following concerns about a potential increased risk of non-arteritic anterior ischemic optic neuropathy (NAIO
- Nordic Pharma Presents Data and Patient Experience Study for Lacrifill Canalicular Gel at ASCRShttps://modernod.com/news/nordic-pharma-presents-data-and-patient-experience-study-for-lacrifill-canalicular-gel-at-ascrs/2482756/Nordic Pharma will be presenting recently published patient data and patient experience study for Lacrifill Canalicular Gel, a novel therapy for dry eye symptoms, during the ASCRS annual meeting in Los Angeles. The April issue of Ca
- FDA Denies Regeneron's BLA for Extended Dosing Intervals for Eylea HDhttps://modernod.com/news/fda-denies-regenerons-bla-for-extended-dosing-intervals-for-eylea-hd/2482747/Regeneron announced that the FDA has issued a complete response letter (CRL) regarding the supplemental Biologics License Application (sBLA) for the addition of extended dosing intervals (up to every 24 weeks) for Eylea HD (aflibercept) Injection 8 mg across all approved indication
- FDA Once Again Rejects Aldeyra's NDA of Reproxalap for Dry Eye Diseasehttps://modernod.com/news/fda-once-again-rejects-aldeyras-nda-of-reproxalap-for-dry-eye-disease/2482727/The FDA issued a complete response letter declining to approve Aldeyra Therapeutics' resubmitted new drug application (NDA) of reproxalap, an investigational drug candidate for the treatment of dry eye disease. Although no manufacturing or safety issues with repr
- Call for Nominations: Prevent Blindness Seeks to Honor Leaders in Vision Healthhttps://modernod.com/news/call-for-nominations-prevent-blindness-seeks-to-honor-leaders-in-vision-health/2482661/Prevent Blindness, one of the nation’s largest eye health and safety nonprofit organizations, issued their call for nominations for the “
- EMA Endorses Macustar's Work on Early AMD Clinical Trialshttps://modernod.com/news/ema-endorses-macustars-work-on-early-amd-clinical-trials/2482631/The European Medicines Agency (EMA) has issued its third 'Letter of Support' to the Macustar consortium, a European public-private partnership focused on advancing clinical trial methodologies for early-stage age-related macular degeneration (AMD). This endorsement follows the consortium&
- Scientists Explore Regrowth of Optic Nerves as Potential Treatment for Glaucomahttps://modernod.com/news/scientists-explore-regrowth-of-optic-nerves-as-potential-treatment-for-glaucoma/2482591/University of Connecticut scientists have published a report in the September issue of Experimental Neurology, showing injured optic nerves can regrow towards the brain if treated properly. Blunt trauma to t